Kathryn Rudie Harrigan
Geen lopende functies
Profiel
Kathryn Rudie Harrigan served as an Independent Director at Cambrex Corp.
from 1994 to 2019.
She was also a Member of the Governors Board at Ronin Development Corp.
Additionally, she worked as a Professor at Columbia Business School.
Prior to her career, she earned an undergraduate degree from Macalester College, an MBA from The University of Texas at Austin, and a doctorate from Harvard University.
Eerdere bekende functies van Kathryn Rudie Harrigan
| Bedrijven | Functie | Einde |
|---|---|---|
| CAMBREX CORPORATION | Directeur/Bestuurslid | 04-12-2019 |
| The Trustees of Columbia University in The City of New York | Corporate Officer/Principal | - |
| Ronin Development Corp. | Directeur/Bestuurslid | - |
| Columbia Business School | Corporate Officer/Principal | - |
Opleiding van Kathryn Rudie Harrigan
| Macalester College | Undergraduate Degree |
| The University of Texas at Austin | Masters Business Admin |
| Harvard University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Cambrex Corp.
 Cambrex Corp. Pharmaceuticals: GenericHealth Technology Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies. Its products include generic and branded APIs, controlled substances, chiral compounds, high potency APIs, and advanced intermediates. The company was founded by Arthur Mendolia and Cyril C. Baldwin Jr. in 1981 and is headquartered in East Rutherford, NJ. | Health Technology |
| Ronin Development Corp. |
